1-4 of 4
Axel Florschuetz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Dietger Niederwieser, MD, Verena Sophia Hoffmann, Dr., Markus Pfirrmann, PhD, Haifa Kathrin Al-Ali, MD, Sebastian Schwind, MD, Vladan Vucinic, MD, Rainer Krahl, PhD, Christoph Kahl, Hans-Heinrich Wolf, MD, Ute Kreibich, Prof., Detlef Hähling, Ute Hegenbart, MD, Carsten Hirt, Norma Peter, MD, Axel Florschuetz, Kolja Reifenrath, Antje Schulze, Niklas Zojer, MD, Sebastian Scholl, Christian Junghanss, MD, Wolfram Pönisch, Simone Heyn, MD, Herbert G. Sayer, Andreas Hochhaus, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Alwin Krämer, MD, Peter Dreger, MD, Georg Maschmeyer, MD, Utz Krug, Maria Christina Sauerland, MSc, Achim Heinecke, Rüdiger Hehlmann, MD, Eva Lengfelder, MD, Wolfgang Hiddemann, MD, Hubert Serve, MD, Carsten Müller-Tidow, Wolfgang E Berdel, MD, Thomas Büchner
Journal: Blood
Blood (2016) 128 (22): 1066.
https://doi.org/10.1182/blood.V128.22.1066.1066
Published: 2016
Journal Articles

Ten Year Follow up Analysis of the OSHO Phase III Trial (AML 96) Comparing Different Application Modes of AraC in Patients below 60 Years with Acute Myeloid Leukemia (AML): No Impact of AraCApplication Mode on Remission Rate, Toxicity, Disease-Free Survival or Overall Survival

Cornelia Becker, Rainer Krahl, Antje Schulze, Georg Maschmeyer, Christian Junghanß, Astrid Franke, Norma Peter, Mathias Haenel, Ulrich Wedding, Hans-Heinrich Wolf, Detlev Haehling, Johannes Meran, Gottfried Doelken, Dietrich Kaempfe, Erika Kettner, Norbert Grobe, Axel Florschuetz, Ute Kreibich, Veronika Schirmer, Thomas Ittel, Mathias Schulze, Renate Huhn, Ernst Zschuppe, Bernd Opitz, Michael Assmann, Dirk Hasenclever, Wolfram Poenisch, Werner Helbig, Dietger W. Niederwieser, MD
Journal: Blood
Blood (2008) 112 (11): 2966.
https://doi.org/10.1182/blood.V112.11.2966.2966
Published: 2008
Journal Articles

Increased Leukaemia Free Survival (LFS) in Patients with Cytogenetic High Risk AML after Related or Unrelated Hematopoietic Cell Transplantation (HCT) Compared to Chemotherapy in the OSHO 96 and 2002 Studies.

Dietger Niederwieser, MD, Cornelia Becker, MD, Rainer Krahl, Ph.D., Haifa-Kathrin Al-Ali, MD, Simone Heyn, MD, Michael Cross, Ph.D., Thoralf Lange, MD, Anke Gerhardt, MD, Antje Schulze, MD, Detleff Haehling, MD, Manfred Schulze, MD, Matthias Freund, MD, Erika Kettner, MD, Gottfried Dölken, MD, Michael Assmann, MD, Hans-Heinrich Wolf, MD, Ernst Zschuppe, MD, Norma Peter, MD, Astrid Franke, MD, Ulrich Wedding, MD, Lutz Uharek, MD, Ute Kreibich, MD, Norbert Grobe, MD, Thomas Ittel, MD, Axel Florschuetz, MD, Bernd Opitz, MD, Karin Senftleben, MD, Veronika Schirmer, MD, Friedrich Fiedler, MD, Renate Huhn, MD, Werner Helbig, MD
Journal: Blood
Blood (2006) 108 (11): 264.
https://doi.org/10.1182/blood.V108.11.264.264
Published: 2006
Journal Articles

Early Allogenic Transplantation Improves Overall Survival (OS) and Event Free Survival (EFS) Independently of the Applied Chemotherapy in AML Patients with Unfavourable Cytogenetic Karyotype.

Cornelia Becker, Rainer Krahl, Haifa Al Ali, Simone Heyn, Wolfram Poenisch, Michael Cross, Thoralf Lange, Anke Gerhardt, Antje Schulze, Detlev Haehling, Manfred Schulze, Mathias Freund, Erika Kettner, Gottfried Doelken, Michael Assmann, Hans-Heinrich Wolf, Ernst Zschuppe, Norma Peter, Astrid Franke, Ullrich Wedding, Lutz Uharek, Ute Kreibich, Norbert Grobe, Thomas Ittel, Axel Florschuetz, Bernhard Opitz, Kristiane Senftleben, Veronika Schirmer, Klaus Fenchel, Friedrich Fiedler, Renate Huhn, Niklas Zojer, Werner Helbig, Dietger Niederwieser
Journal: Blood
Blood (2006) 108 (11): 1921.
https://doi.org/10.1182/blood.V108.11.1921.1921
Published: 2006